These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8549295)

  • 1. Resistance among important pathogens and the antimicrobial activity of parenteral fluoroquinolones at 43 US medical centres.
    Jones RN; Kehrberg EN; Erwin ME
    Drugs; 1995; 49 Suppl 2():179-81. PubMed ID: 8549295
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluoroquinolone resistance: mechanisms and epidemiology.
    Tillotson GS; Dorrian I; Blondeau J
    J Med Microbiol; 1997 Jun; 46(6):457-61. PubMed ID: 9379475
    [No Abstract]   [Full Text] [Related]  

  • 3. Emergence of resistance to fluoroquinolones among bacteria causing infections in food animals in Denmark.
    Aarestrup FM; Jensen NE; Jorsal SE; Nielsen TK
    Vet Rec; 2000 Jan; 146(3):76-8. PubMed ID: 10674696
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro antimicrobial activity of CP-99,219, a new 7-azabicyclonaphthyridone.
    Jones RN
    Drugs; 1995; 49 Suppl 2():205-7. PubMed ID: 8549305
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology of quinolone resistance: Europe and North and South America.
    Goldstein FW; Acar JF
    Drugs; 1995; 49 Suppl 2():36-42. PubMed ID: 8549361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of E-4695, a new fluoronaphthyridine antimicrobial agent.
    Mirelis B; Miró E; Navarro F; Prats G
    J Antimicrob Chemother; 1994 May; 33(5):1017-23. PubMed ID: 8089047
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tosufloxacin tosilate].
    Shimada K
    Jpn J Antibiot; 1990 Apr; 43(4):583-602. PubMed ID: 2199687
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in susceptibility to ciprofloxacin in a community in northern Israel.
    Cahana Z; Gilboa A; Raz R
    Drugs; 1995; 49 Suppl 2():173-4. PubMed ID: 8549292
    [No Abstract]   [Full Text] [Related]  

  • 9. Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.
    Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
    Drugs Exp Clin Res; 1992; 18(8):311-7. PubMed ID: 1338041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo antibacterial activities of CFC-222, a novel broad spectrum fluoroquinolone.
    Park KH; Cho IH; Lee JM; Kang JA; Kim YG; Hong KH; Kim JH; Nishino T
    Drugs; 1995; 49 Suppl 2():240-2. PubMed ID: 8549317
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring of antimicrobial resistance in pathogenic bacteria from livestock animals.
    Wallmann J
    Int J Med Microbiol; 2006 Jun; 296 Suppl 41():81-6. PubMed ID: 16530479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of fluoroquinolone resistance.
    Chen FJ; Lo HJ
    J Microbiol Immunol Infect; 2003 Mar; 36(1):1-9. PubMed ID: 12741725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of lomefloxacin (NY-198 or SC-47111), a new difluoro-quinolone.
    Jones RN
    J Chemother; 1989 Jul; 1(4 Suppl):165-7. PubMed ID: 16312353
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity.
    Cutarelli PE; Lass JH; Lazarus HM; Putman SC; Jacobs MR
    Curr Eye Res; 1991 Jun; 10(6):557-63. PubMed ID: 1893771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activity of BAY Y 3118 with other fluoroquinolones.
    Molinari G; Schito GC
    Drugs; 1995; 49 Suppl 2():222-5. PubMed ID: 8549310
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fluoroquinolones--a current review].
    Christ W; Kemmler H
    Med Monatsschr Pharm; 2001 Jul; 24(7):215-25. PubMed ID: 11486553
    [No Abstract]   [Full Text] [Related]  

  • 17. Resistance of Streptococcus pneumoniae to fluoroquinolones--United States, 1995-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Sep; 50(37):800-4. PubMed ID: 11785571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolones in animal health.
    Brown SA
    J Vet Pharmacol Ther; 1996 Feb; 19(1):1-14. PubMed ID: 8992019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of quinolone resistance. Eastern hemisphere.
    Turnidge J
    Drugs; 1995; 49 Suppl 2():43-7. PubMed ID: 8549389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of ceftaroline and other anti-infective agents against microbial pathogens recovered from the surgical intensive care patient population: a prevalence analysis.
    Edmiston CE; Krepel CJ; Leaper D; Ledeboer NA; Mackey TL; Graham MB; Lee C; Rossi PJ; Brown KR; Lewis BD; Seabrook GR
    Surg Infect (Larchmt); 2014 Dec; 15(6):745-51. PubMed ID: 24896013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.